Product Information
HYDROCODONE-IBUPROFEN 10-200 is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $3.3604 per EA under NDC 53746011701. Its NADAC has been published 666 times since Nov 28, 2013.
FDA first approved this application on Mar 18, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 200 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746011701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCODONE BITARTRATE; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA076642FDA Approved
3/18/2004
TE Code
AB
On Market Since
2/18/2010
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-IBUPROFEN 10-200 has been published 666 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3604 per EA |
|---|---|
| All-time high | $3.6836 (Apr 15, 2015) |
| All-time low | $1.7219 (Oct 18, 2017) |
| 52-week high | $3.4846 |
| 52-week low | $3.3604 |
| Median price | $3.1374 |
| Average price | $2.9923 |
| Largest weekly change | +53.6% (Jul 20, 2016) |
| Weeks tracked | 666 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydrocodone Bitartrate and Ibuprofen market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocodone Bitartrate and Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE-IBUPROFEN 10-200?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-IBUPROFEN 10-200, manufactured by Amneal Pharmaceuticals of New York LLC, is $3.3604 per EA (NDC 53746011701), effective Sep 30, 2026.
How has the price of HYDROCODONE-IBUPROFEN 10-200 changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-IBUPROFEN 10-200 has held within roughly two percent of its current level. It has been tracked across 666 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-IBUPROFEN 10-200?
Since Nov 28, 2013, the NADAC for HYDROCODONE-IBUPROFEN 10-200 has ranged from a low of $1.7219 (Oct 18, 2017) to a high of $3.6836 (Apr 15, 2015), with a median of $3.1374 per EA.
Are there cheaper alternatives to HYDROCODONE-IBUPROFEN 10-200?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCODONE-IBUPROFEN 10-200 in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCODONE-IBUPROFEN 10-200?
HYDROCODONE-IBUPROFEN 10-200 (NDC 53746011701) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.